HPV Self-sampling cost effectiveness model

Department of Health and Social Care (London) · awarded 14 October 2024

Who

Buyer	Department of Health and Social Care (London) London
Supplier	The University of Sydney
Category	services
Classification	Research and development consultancy services CPV 73200000
Notice published	14 October 2024

What it is for

The HPV self-sampling ISE will offer a portion of women eligible for cervical screening in England the choice between a clinician taken sample and a self-sample for HPV. The UK NSC has appointed the University of Sydney to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample. Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion. Contract term: 18 months with the option to extend for a period of up to 6 months. Contract value (including extensions): £249,876 excluding VAT (£299,852 including VAT).

Read the original award notice on Contracts Finder →

Other contracts from this buyer

14 awards on file, worth £37.6m.

Everything Department of Health and Social Care (London) has awarded →

Other contracts won by this supplier

2 awards on file, worth £600k.

Everything The University of Sydney has won →